Researchers will discuss the many ways they are using Bio-Rad Laboratories, Inc.‘s QX100 Droplet Digital PCR system to achieve their research goals at the 2nd QX100 User Group Meeting to be held Dec. 6–7, 2012 in Boston.
The QX100™ Droplet Digital PCR (ddPCR™) system enables researchers at Sangamo BioSciences, Inc. to accurately detect rare mutations in HIV+ patients. The highly precise and reproducible data obtained with the QX100 system puts the company one step closer to identifying a functional cure for HIV.
The QX100™ Droplet Digital PCR (ddPCR™) system has demonstrated superior performance over existing methods for key research applications and is emerging as a platform for next-generation sequencing validation. The diverse applications of ddPCR technology will be explored at the first Digital PCR Conference in San Diego, CA, Oct. 15–16, 2012.